Roche gets FDA clearance for STI test panels
Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.
H.C. Wainwright Remains a Buy on Adaptimmune Therapeutics (ADAP)
In a report released today, Arthur He CFA from H.C. Wainwright maintained a Buy rating on Adaptimmune Therapeutics (ADAP – Research Report), ...
One new option listing and ten option delistings on January 22nd
New option listings for January 22nd include Lennar . Option delistings effective January 22nd include POSEIDA THERAPEUTICS INC. (PSTX), DUCKHORN PORTFOLIO INC. (NAPA), Manitex In ...